Finance

Beta
Lists
MNPR:NASDAQ
Monopar Therapeutics Inc
၈၇.၆၈ US$
+၀.၀၆%
(+၀.၀၅၀) 1D
၈၇.၆၈ US$
-၀.၀၀% (-၀.၀၀၁၆)
After hours
Closed: ဇွန် ၂၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MNPR...
Open
၈၇.၆၄ US$
High
၉၂.၂၆ US$
Low
၈၅.၇၀ US$
Mkt. cap
၅၈.၇၄ ကုဋေ
Avg. vol.
၁.၇၄ သိန်း
Volume
၃.၁၀ သိန်း
52-wk high
၁၀၅.၀၀ US$
52-wk low
၂၉.၁၈ US$
EPS
-၁.၉၀ US$
Beta
၁.၅၂
Shares outstanding
၆.၇၀ သန်း
No. of employees
၂၂
Open
၈၇.၆၄ US$
High
၉၂.၂၆ US$
Low
၈၅.၇၀ US$
Mkt. cap
၅၈.၇၄ ကုဋေ
Avg. vol.
၁.၇၄ သိန်း
Volume
၃.၁၀ သိန်း
52-wk high
၁၀၅.၀၀ US$
52-wk low
၂၉.၁၈ US$
EPS
-၁.၉၀ US$
Beta
၁.၅၂
Shares outstanding
၆.၇၀ သန်း
No. of employees
၂၂
News stories
From sources across the web
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၄ နာရီ
Monopar Therapeutics (MNPR) to Present New Data on ALXN1840 at E
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၅ နာရီ
ALXN1840 Phase 3 data back NDA plan for Wilson disease, Monopar (NASDAQ: MNPR)
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၅ နာရီ
Monopar’s Wilson disease drug shows stronger neurologic gains in Phase 3
About Monopar Therapeutics Inc
CEO-
Employees၂၂
Founded၂၀၁၄
HeadquartersWilmette, အီလီနွိုင်းပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitemonopartx.com
Analyst ratings
Based on 9 analysts giving stock ratings to MNPR in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for MNPR in the last 3 months.
Highest
Current ၈၇.၆၈ US$
၁၃၀.၀၀ US$ (+၄၈.၂၇%)
Average
၁၁၁.၈၉ US$ (+၂၇.၆၁%)
Lowest
၁၀၁.၀၀ US$ (+၁၅.၁၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Biren Amin
Piper Sandler
Buy
Maintained
၁၀၁.၀၀ US$
+၁၅.၂%
06/02/2026
Jeet Mukherjee
BTIG
Buy
Maintained
၁၀၄.၀၀ US$
+၁၈.၆%
06/01/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
၁၀၅.၀၀ US$
+၁၉.၈%
06/02/2026
Chad Messer
Lake Street
Buy
Maintained
၁၀၃.၀၀ US$
+၁၇.၅%
06/01/2026
Maxwell Skor
Morgan Stanley
Buy
Maintained
၁၁၅.၀၀ US$
+၃၁.၂%
05/18/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
၁၁၅.၀၀ US$
+၃၁.၂%
05/15/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
၁၀၉.၀၀ US$
+၂၄.၃%
05/14/2026
Etzer Darout
Barclays
Buy
Maintained
၁၂၅.၀၀ US$
+၄၂.၆%
05/15/2026
Boris Peaker
JonesTrading
Buy
Maintained
၁၃၀.၀၀ US$
+၄၈.၃%
05/14/2026
Soumit Roy
JonesTrading
Buy
Maintained
၁၃၀.၀၀ US$
+၄၈.၃%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၇၃ သန်း
၂.၅၉ သန်း
၃.၉၄ သန်း
၃.၄၉ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၅၀ သန်း
၁.၅၀ သန်း
၂.၂၁ သန်း
၁.၇၄ သန်း
Operating expense
၃.၂၃ သန်း
၄.၀၉ သန်း
၆.၁၆ သန်း
၅.၂၃ သန်း
Total operating expenses
၃.၂၃ သန်း
၄.၀၉ သန်း
၆.၁၆ သန်း
၅.၂၃ သန်း
Operating income
-၃.၂၃ သန်း
-၄.၀၉ သန်း
-၆.၁၆ သန်း
-၅.၂၃ သန်း
Other non operating income
-
၁.၀၀
-၁.၀၀
-
EBT including unusual items
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
EBT excluding unusual items
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၅
-၀.၄၈
-၀.၆၁
-၀.၄၆
Interest and investment income
၇.၈၁ သိန်း
၆.၅၅ သိန်း
၉.၅၄ သိန်း
၁.၃၃ သန်း
Interest expense
-
-
-
-
Net interest expenses
၇.၈၁ သိန်း
၆.၅၅ သိန်း
၉.၅၄ သိန်း
၁.၃၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of MNPR
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer